AVNSのチャート
AVNSの企業情報
| symbol | AVNS |
|---|---|
| 会社名 | Avanos Medical Inc （AVNS アバノス・メディカル） |
| 分野（sector） | |
| 産業（industry） | |
| 業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care） |
| 概要 | 事業概要 アバノス・メディカル(Avanos Medical Inc.)（旧名：Halyard Health Inc.）は医療技術会社である。同社は、主に手術・Interventional pain management、呼吸器及び消化器の健康を中心とする製品ポートフォリオを提供する。同社の製品には、術後の疼痛管理ソリューション、低侵襲介入または慢性疼痛治療、閉鎖式気道吸引システム及び経腸栄養チューブがある。同社の製品は「ON-Q」、「COOLIEF」、「MICROCUFF」、「MIC-KEY」、「QUIKBLOC」、「HOMEPUMP」及び「CORTRAK」などのブランド名で販売される。 ハリヤ―ド・ヘルスは米国の医療関連会社。感染管理、医療安全を考慮した製品を提供。主要製品は、サ―ジカルガウン、サ―ジカルドレ―ブ、アイソレ―ションガウン、防水ガウン、減菌包装材、フェイシャルプロテクション、検査検診用グロ―ブ、手術用微生物シ―ラント、閉鎖型気管内吸引カテ―テル、経腸栄養チュ―ブなど。100カ国以上の国で製品を販売。 Avanos Medical is a medical technology company focused on delivering clinically superior breakthrough medical device solutions to improve patients' quality of life. Headquartered in Alpharetta, Georgia, Avanos is committed to addressing some of today's most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery. Avanos develops, manufactures and markets its recognized brands in more than 90 countries. |
| 本社所在地 | 844 428-2667 |
| 代表者氏名 | Ronald W. Dollens |
| 代表者役職名 | Independent Chairman of the Board |
| 電話番号 | +1 678-425-9273 |
| 設立年月日 | 41671 |
| 市場名 | NYSE（ニューヨーク証券取引所） |
| ipoyear | 年 |
| 従業員数 | 4700人 |
| url | www.avanos.com |
| nasdaq_url | |
| adr_tso | |
| EBITDA | EBITDA（百万ドル） 65.60000 |
| 終値（lastsale） | |
| 時価総額（marketcap） | |
| 時価総額 | 時価総額（百万ドル） 2025.30500 |
| 売上高 | 売上高（百万ドル） 652.30000 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 1888.50500 |
| 当期純利益 | 当期純利益（百万ドル） -12.40000 |
| 決算概要 | 決算概要 BRIEF: For the fiscal year ended 31 December 2018 Avanos Medical Inc revenues increased 7% to $652.3M. Net loss before extraordinary items decreased 71% to $12.4M. Revenues reflect North America segment increase of 7% to $505.3M Asia Pacific and Latin America segment increase of 10% to $59.7M. Lower net loss reflects Interest income increase from $2.5M to $7.8M (income) Interest expense decrease of 16% to $26.4M (expense). |
AVNSのテクニカル分析
AVNSのニュース
Looking Into Avanos Medical''s Return On Invested Capital 2023/02/22 14:48:46 Benzinga
According to Benzinga Pro, during Q4, Avanos Medical (NYSE: AVNS ) earned $16.90 million, a 7.64% increase from the preceding quarter. Avanos Medical also posted a total of $217.50 million in sales, a 7.62% increase since Q3. In Q3, Avanos Medical earned $15.70 million, and total sales reached $202.10 million. Why Is ROIC Significant? Return on Invested Capital is a measure of yearly pre-tax profit relative to capital invested by a business. Changes in earnings and sales indicate shifts in a company''s ROIC. A higher ROIC is generally representative of successful growth … Full story available on Benzinga.com
Avanos Medical: Q4 Earnings Snapshot 2023/02/21 12:54:13 WTOP
ALPHARETTA, Ga. (AP) — ALPHARETTA, Ga. (AP) — Avanos Medical, Inc. (AVNS) on Tuesday reported fourth-quarter earnings of $16.9 million.…
Avanos Medical reports mixed Q4 earnings; initiates FY23 outlook 2023/02/21 12:15:55 Seeking Alpha
Avanos Medical press release (AVNS): Q4 Non-GAAP EPS of $0.60 beats by $0.11.Revenue of $217.5M (+12.2% Y/Y) misses by $0.3M.Fourth quarter free cash flow was $29M following $23M in…
Earnings Outlook For Avanos Medical 2023/02/20 17:01:07 Benzinga
Avanos Medical (NYSE: AVNS ) is set to give its latest quarterly earnings report on Tuesday, 2023-02-21. Here''s what investors need to know before the announcement. Analysts estimate that Avanos Medical will report an earnings per share (EPS) of $0.49. Avanos Medical bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the … Full story available on Benzinga.com
Avanos Medical Q4 2022 Earnings Preview (NYSE:AVNS) 2023/02/20 14:45:42 Seeking Alpha
Avanos Medical (AVNS) is scheduled to announce Q4 earnings results on Tuesday, February 21st, before market open.The consensus EPS Estimate is $0.49 (+6.5% Y/Y) and the consensus…
Avanos Medical Inc. (AVNS) is an excellent investment, but the stock is overvalued/undervalued right now 2023/01/02 16:08:00 US Post News
The share price of Avanos Medical Inc. (NYSE:AVNS) fell to $27.06 per share on Friday from $27.37. While Avanos Medical Inc. has underperformed by -1.13%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, AVNS fell by -21.50%, with highs and lows ranging from $36.22 to $19.32, […]
Avanos Medical Earnings, Revenue Miss in Q3 By Investing.com 2022/11/07 01:02:00 Investing.com
Avanos Medical Earnings, Revenue Miss in Q3
Avanos Medical reports Q3 mixed earnings; reaffirms FY22 guidance 2022/11/02 11:16:09 Seeking Alpha
Avanos Medical press release (AVNS): Q3 Non-GAAP EPS of $0.38 beats by $0.03.Revenue of $202M (+9.7% Y/Y) misses by $3.47M.Adjusted gross margin was 56 percent, compared to 52…
Avanos Medical Q3 2022 Earnings Preview 2022/11/01 17:33:56 Seeking Alpha
Avanos Medical (AVNS) is scheduled to announce Q3 earnings results on Wednesday, November 2nd, before market open.The consensus EPS Estimate is $0.35 (+40.0% Y/Y) and the consensus Revenue…
Avanos: Entry To Hyaluronic Acid Market Sparks Interesting Debate (NYSE:AVNS) 2022/09/12 09:37:24 Seeking Alpha
Avanos'' acquisition of TriVisc portfolio creates an interesting debate for those following hyaluronic acid market. Read more for AVNS stock''s full investment analysis.
Avanos Medical Inc. (AVNS) is an excellent investment, but the stock is overvalued/undervalued right now 2023/01/02 16:08:00 US Post News
The share price of Avanos Medical Inc. (NYSE:AVNS) fell to $27.06 per share on Friday from $27.37. While Avanos Medical Inc. has underperformed by -1.13%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, AVNS fell by -21.50%, with highs and lows ranging from $36.22 to $19.32, […]
Avanos Medical Earnings, Revenue Miss in Q3 By Investing.com 2022/11/07 01:02:00 Investing.com
Avanos Medical Earnings, Revenue Miss in Q3
Avanos Medical reports Q3 mixed earnings; reaffirms FY22 guidance 2022/11/02 11:16:09 Seeking Alpha
Avanos Medical press release (AVNS): Q3 Non-GAAP EPS of $0.38 beats by $0.03.Revenue of $202M (+9.7% Y/Y) misses by $3.47M.Adjusted gross margin was 56 percent, compared to 52…